MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1080/0886022x.2023.2207671

Медицинская библиотека · Renal failure · 2023

Efficacy and safety of belimumab therapy in lupus nephritis: a systematic review and meta-analysis.

Zhang Han, Chen Juan, Zhang Ying, Zhao Na, Xu Dongmei

МетаанализСистематический обзорСтатьяПеревод в очереди

Аннотация

BACKGROUND

Belimumab is the first biological agent approved for the treatment of systemic lupus erythematosus (SLE), but the efficacy of belimumab for lupus nephritis (LN) is not clear. We conducted this meta-analysis and systematic review to compare the efficacy and safety of belimumab with those of conventional therapy for LN.

METHODS

PubMed, EMBASE, Cochrane Library, Clinical Trials.gov were searched in 31 December 2022 to identify relevant adult human studies reporting effectiveness outcomes of belimumab in patients with LN. Review manager (RevMan 5.4) was used for data analysis with fixed effects model based on heterogeneities.

RESULTS

Six randomized controlled trials (RCTs) were included in the quantitative analysis. A total of 2960 participants were identified. Belimumab plus standard therapy significantly improved total renal response rates (RR, 1.31; 95% CI, 1.11-1.53; p = 0.001) and complete renal RRs (1.47; 95% CI, 1.07-2.02; p = 0.02) compared with the control plus standard therapy group. It significantly reduced the risk of renal flare (RR, 0.51; 95% CI, 0.37-0.69; p < 0.001) and renal function worsening or progression to end-stage renal disease (ESRD) (RR, 0.56; 95% CI, 0.40-0.79; p = 0.001). When assessed with the incidence of adverse events, no significant differences between the two groups were observed for the occurrence of treatment-related adverse events (RR, 1.04; 95% CI, 0.99-1.09; p = 0.12).

CONCLUSIONS

This meta-analysis showed that belimumab plus standard therapy was more effective and had a favorable safety in patients with LN.

Для цитирования: Zhang Han, Chen Juan, Zhang Ying, Zhao Na, Xu Dongmei. Efficacy and safety of belimumab therapy in lupus nephritis: a systematic review and meta-analysis.. Renal failure. 2023. DOI: 10.1080/0886022x.2023.2207671.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.